Huagai Capital
GL Capital leads $290m investment in China’s Sangon Biotech
Chinese healthcare-focused private equity firm GL Capital has led a CNY2bn (USD 290m) investment in local life sciences company Sangon Biotech.
Baidu-backed autonomous truck developer raises $67m
DeepWay, an intelligent driving solutions provider for trucks established by Baidu, has raised a Series A round of CNY 460m (USD 67m) led by Qiming Venture Partners.
China biotech player Reistone raises $100m
Reistone, a novel drug developer incubated by Jiangsu Hengrui Pharmaceuticals, has raised a Series A of nearly USD 100m led by Huagai Capital.
China biotech player GenFleet raises $75m
GenFleet Therapeutics, a Chinese biotech developer focused on oncology and immunology, has secured a USD 75m Series C round led by Huagai Capital.
DCP leads $235m round for China's Datong Insurance
DCP Capital Partners has become the largest institutional shareholder in Datong Insurance Service, one of China’s leading insurance brokerages, after leading a RMB1.5 billion ($235 million) round.
Sherpa Healthcare leads Series A for Paq Therapeutics
Sherpa Healthcare Partners has led a $30 million Series A for Paq Therapeutics, a Chinese-founded biotech company specializing in treatments based on molecules that enhance the degradation of disease-causing entities.
TR, Shenzhen Capital back renminbi continuation fund
TR Capital and Shenzhen Capital Group have backed the spin-out of six healthcare assets held by China focused GP Huagai Capital into a RMB800 million ($125 million) renminbi-denominated continuation fund.